Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Protagonist Therapeutics, Inc.
  6. Charts
  7. Technical Analysis
    PTGX   US74366E1029

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-07 pm EST
15.83 USD   +5.82%
01/11Transcript : Protagonist Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 07:30 AM
CI
01/06Protagonist Therapeutics, Inc : Change in Directors or Principal Officers (form 8-K)
AQ
01/06Protagonist Therapeutics, Inc. Announces David Liu, Chief R&D Strategy Officer, Transitioned to Part-Time R&D Strategy Advisor
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 Technical AnalysisHistorical ChartNews ChartSector ChartComparison ChartReversed ChartRelative Strength Chart
Static chartExpert dynamic chartDynamic Chart 
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance16,219,227,2
Spread/Res.-2,5%-18%-42%
Spread/Supp.24%38%116%
Support12,811,57,33
Notations Surperformance© of Protagonist Therapeutics, Inc.  Help  
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes